Isaksson, J.
Van’t Westeinde, A.
Cauvet, É.
Kuja-Halkola, R.
Lundin, K.
Neufeld, J.
Willfors, C.
Bölte, S.
Funding for this research was provided by:
Vetenskapsrådet
VINNOVA
Svenska Forskningsrådet Formas
FORTE
Hjärnfonden
Stockholm Brain Institute
Autism and Asperger Association Stockholm
Queen Silvia Jubilee Fund
Stiftelsen Solstickan
PRIMA Child and Adult Psychiatry
The Pediatric Research Foundation at Astrid Lindgren Children's Hospita
The Swedish Foundation for Strategic Research
Jerring Foundation
The Swedish Order of Freemasons
Kempe-Carlgrenska Foundation
Sunnderdahls Handikappsfond
The Jeansson Foundation
The Innovative Medicines Initiative Joint Undertaking (115300)
Article History
First Online: 10 April 2019
Compliance with Ethical Standards
:
: The authors declare no conflict of interest related to this study. Bölte discloses that he has in the last three years acted as an author, consultant or lecturer for Shire, Medice, Roche, Eli Lilly, Prima Psychiatry, GLGroup, System Analytic, Kompetento, Expo Medica, Prophase, and receives royalties for text books or diagnostic instruments from Huber/Hogrefe, Kohlhammer and UTB.
: All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study after the nature of the procedure had been fully explained.